Message #1 From:
Jason Date: May 28, 2007 09:21:12 PM
PRXL, PAREXEL Appoints Biomedical and Information Sciences Expert, Dr. Barbara Tardiff, to Vice President of Data Sciences
PAREXEL International Corporation (Nasdaq: PRXL Stock Message Boards), a leading global bio/pharmaceutical services organization, has appointed Dr. Barbara Tardiff, M.D., M.S., M. Phil. to the newly created position of Corporate Vice President of Data Sciences. Drawing from nearly 25 years of experience in medicine, information management, and clinical research, Dr. Tardiff will lead the expansion of PAREXEL's data services including data management, biostatistics and related applications of information technology.
Dr. Tardiff joins the organization after two and a half years with Merck & Co. where she was Executive Director, Research Information Services. She previously served as Vice President of Informatics, Data Management and Biostatistics at Regeneron Pharmaceuticals.
'PAREXEL's clients are anticipated to benefit significantly from Dr. Tardiff's depth of experience in applying information technology to clinical development,' said Mark A. Goldberg, M.D., President, Clinical Research Services and Perceptive Informatics at PAREXEL. 'With her leadership and guidance, PAREXEL will be able to better leverage it's clinical and technology expertise.'
'It is a pleasure to be working with some of the industry's most notable physicians, researchers and technologists,' said Dr. Tardiff. 'PAREXEL is known for its technology and clinical expertise. I am excited to have the opportunity to bring these two strengths together and apply them to the challenges and opportunities that our customers face, such as adaptive clinical trials.'
Dr. Tardiff is certified by the American Board of Pediatrics and the American Board of Anesthesiology and completed a clinical research fellowship at the Duke Clinical Research Institute. She currently holds several prestigious consultancy appointments including Assistant Consulting Professor, Duke University School of Medicine and is an occasional lecturer at Fuqua School of Business, Duke University. She is a member of the Drug Information Association's (DIA) Information Technology Track Program Committee and has been an active participant in various Health Information Technology forums. Dr. Tardiff is also active in industry standards initiatives such as CDISC and Health Level Seven (HL7), and served as co-chair of the HL7 Regulated Clinical Information Management Technical Committee for five years. Her research has been featured in numerous publications including the Journal of the American College of Cardiology and the American Heart Journal.
Dr. Tardiff holds an MD from Yale University, an MBA from Duke University, Fuqua School of Business, an MS, M. Phil from Yale University, and a BS from Oregon State University. She is based at PAREXEL's worldwide headquarters in Waltham, Massachusetts.
About PAREXEL International
PAREXEL International Corporation is a leading global bio/pharmaceutical services organization, providing a broad range of knowledge-based contract research, medical communications and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates in 55 locations throughout 43 countries around the world, and has over 6,315 employees. For more information about PAREXEL International visit www.PAREXEL.com.
